NorthCrest Asset Manangement’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.1M Buy
97,027
+5,855
+6% +$771K 0.34% 73
2026
Q1
$12.7M Sell
91,172
-31,555
-26% -$4.42M 0.4% 71
2025
Q4
$14.5M Buy
122,727
+1,502
+1% +$183K 0.32% 88
2025
Q3
$14.2M Buy
121,225
+2,060
+2% +$234K 0.34% 88
2025
Q2
$13.3M Buy
119,165
+2,126
+2% +$226K 0.36% 82
2025
Q1
$13.1M Buy
117,039
+1,366
+1% +$141K 0.4% 80
2024
Q4
$10.7M Buy
115,673
+98
+0.1% +$8.82K 0.32% 88
2024
Q3
$9.69M Buy
115,575
+1,252
+1% +$95.5K 0.29% 94
2024
Q2
$7.84M Buy
114,323
+1,372
+1% +$91.6K 0.26% 105
2024
Q1
$8.27M Buy
112,951
+4,068
+4% +$313K 0.28% 105
2023
Q4
$8.82M Sell
108,883
-665
-0.6% -$51.7K 0.33% 90
2023
Q3
$8.21M Sell
109,548
-260
-0.2% -$20K 0.33% 95
2023
Q2
$8.46M Sell
109,808
-753
-0.7% -$60.1K 0.34% 96
2023
Q1
$9.17M Buy
110,561
+1,351
+1% +$112K 0.38% 87
2022
Q4
$9.38M Sell
109,210
-2,967
-3% -$235K 0.53% 65
2022
Q3
$6.92M Sell
112,177
-725
-0.6% -$45.7K 0.37% 95
2022
Q2
$6.98M Buy
112,902
+1,828
+2% +$113K 0.36% 100
2022
Q1
$6.6M Buy
111,074
+4,234
+4% +$271K 0.31% 108
2021
Q4
$7.76M Buy
+106,840
New +$7.36M 0.43% 78

Other funds holding GILD

NorthCrest Asset Manangement's GILD Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Gilead Sciences (GILD) stake by 6.4% in Q2 2026, buying an estimated $771K and bringing the position to 97,027 shares worth $13.1M. The position accounts for 0.34% of the portfolio, ranked #73.

NorthCrest Asset Manangement first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.5M in Q4 2025. 353 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • NorthCrest Asset Manangement held 97,027 shares of Gilead Sciences worth $13.1M as of Q2 2026.
  • NorthCrest Asset Manangement bought 5,855 Gilead Sciences shares in Q2 2026, an estimated $771K.
  • Gilead Sciences made up 0.34% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #73 holding.
  • NorthCrest Asset Manangement first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Gilead Sciences position peaked at $14.5M in Q4 2025.
  • 353 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.